Guilford to Present at CIBC World Markets Annual Biotech & Specialty Pharmaceuticals Conference
27 Abril 2004 - 10:40AM
PR Newswire (US)
Guilford to Present at CIBC World Markets Annual Biotech &
Specialty Pharmaceuticals Conference BALTIMORE, April 27
/PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. announced
today that it will present at the CIBC World Markets Annual Biotech
& Specialty Pharmaceuticals Conference on Wednesday, April 28,
2004 at 9:00 a.m. EDT at the Millennium Broadway Hotel in New York,
NY. Guilford's Chairman, President and CEO, Craig R. Smith, M.D.
will provide an update on the Company's business as well as new
developments on products currently in the pipeline. To access the
live audio broadcast or the subsequent archived recording log on to
http://www.guilfordpharm.com/. The link for the webcast is located
under the Investor Relations section of the website under
"conferences." Please connect to the website several minutes prior
to the start of the conference call to ensure adequate time for any
software download that may be necessary. About Guilford Guilford
Pharmaceuticals Inc. is a fully integrated pharmaceutical company
engaged in the research, development and commercialization of
products that target the hospital market. Presently, Guilford
markets two commercial products, GLIADEL(R) Wafer (polifeprosan 20
with carmustine implant), for the treatment of brain cancer, and
AGGRASTAT(R) Injection (tirofiban hydrochloride), a glycoprotein GP
IIb/IIIa receptor antagonist used for the treatment of acute
coronary syndrome (ACS). Guilford's product pipeline includes a
novel anesthetic, AQUAVAN(R) Injection, and drugs for treating
Parkinson's disease and post-prostatectomy erectile dysfunction.
CONTACT: Stacey Jurchison, Director, Corporate Communications,
Guilford Pharmaceuticals, (410) 631-5022; .
http://www.guilfordpharm.com/. DATASOURCE: Guilford Pharmaceuticals
Inc. CONTACT: Stacey Jurchison, Director, Corporate Communications,
Guilford Pharmaceuticals, +1-410-631-5022, Web site:
http://www.guilfordpharm.com/ Company News On-Call:
http://www.prnewswire.com/comp/112882.html
Copyright
Guilford (NASDAQ:GLFD)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Guilford (NASDAQ:GLFD)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Guilford Pharmaceuticals (MM) (NASDAQ): 0 recent articles
Más de Guilford Pharmaceuticals (MM) Artículos de Noticias